Style de citation APA (7e éd.)

KE, S., B, Y., L, S., RH, D., SL, W., HH, Z., . . . MS, S. (2017). Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks. Dove Medical Press.

Style de citation Chicago (17e éd.)

KE, Squires, Young B, Santiago L, Dretler RH, Walmsley SL, Zhao HH, Pakes GE, Ross LL, et Shaefer MS. Response by Gender of HIV-1-infected Subjects Treated with Abacavir/lamivudine Plus Atazanavir, with or Without Ritonavir, for 144 Weeks. Dove Medical Press, 2017.

Style de citation MLA (8e éd.)

KE, Squires, et al. Response by Gender of HIV-1-infected Subjects Treated with Abacavir/lamivudine Plus Atazanavir, with or Without Ritonavir, for 144 Weeks. Dove Medical Press, 2017.